SCHEMBL2356277

SCHEMBL2356277

N#CN(c1ccc(CCCC(=O)O)cc1)C1CCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
MAPT P10636 2/20 0.51
GMNN O75496 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
CYP2D6 P10635 1/20 0.51
GABRA1 P14867 1/20 0.51
TSHR P16473 1/20 0.51
NFKB1 P19838 1/20 0.51
THPO P40225 1/20 0.51
GABRA2 P47869 1/20 0.51
GABRB2 P47870 1/20 0.51
PMP22 Q01453 1/20 0.51
HIF1A Q16665 1/20 0.51
SLCO1B3 Q9NPD5 1/20 0.51
HDAC3 O15379 1/20 0.45
MAPK1 P28482 1/20 0.45
ADRA1A P35348 1/20 0.45
HDAC4 P56524 1/20 0.45
SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922290 0.92 FFAR1 (0.48) SMN1; SMN2MAPTGMNNALDH1A1LMNA
SCHEMBL3885825 0.89 CYP2D6 (0.39) SMN1; SMN2MAPTGMNNALDH1A1LMNA
SCHEMBL3927904 0.83 ENPP2 (0.45) SMN1; SMN2ALDH1A1LMNATSHRFFAR1
SCHEMBL6208836 0.72 SMN1; SMN2 (0.82) SMN1; SMN2MAPTGMNNALDH1A1LMNA
SCHEMBL69789 0.70 SMN1; SMN2 (0.78) SMN1; SMN2MAPTGMNNALDH1A1LMNA
SCHEMBL1336456 0.70 FFAR1 (0.67) SMN1; SMN2MAPTGMNNALDH1A1LMNA
SCHEMBL472311 0.70 ALDH1A1 (0.61) SMN1; SMN2MAPTGMNNALDH1A1LMNA
SCHEMBL19246724 0.69 SMN1; SMN2 (0.50) SMN1; SMN2MAPTGMNNALDH1A1LMNA
SCHEMBL1454883 0.68 FFAR4 (0.60) SMN1; SMN2MAPTHDAC3MAPK1ADRA1A
SCHEMBL7101616 0.68 FFAR4 (0.60) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536708-A2 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF Aragon Pharmaceuticals, Inc. (US) 2012-12-26 EP disclosed
WO-2011103202-A2 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF ARAGON PHARMACEUTICALS, INC. (US) 2011-08-25 WO disclosed
EP-2220050-A2 DIARYLHYDANTOIN COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS The Regents Of The University Of California (US) 2010-08-25 EP disclosed
WO-2009055053-A2 DIARYLHYDANTOIN COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-04-30 WO disclosed
EP-1893196-A4 DIARYLHYDANTOIN COMPOUNDS UNIV CALIFORNIA (US) 2009-03-18 EP disclosed
EP-2013187-A2 DIARYLTHIOHYDANTOIN COMPOUNDS The Regents of the University of California (US) 2009-01-14 EP disclosed
WO-2007127010-A9 DIARYLTHIOHYDANTOIN COMPOUNDS UNIV CALIFORNIA (US) 2008-05-22 WO disclosed
EP-1893196-A1 DIARYLHYDANTOIN COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-03-05 EP disclosed
WO-2007127010-A2 DIARYLTHIOHYDANTOIN COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-11-08 WO disclosed
WO-2006124118-A1 DIARYLHYDANTOIN COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-11-23 WO disclosed